Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other Latest News
- New Tool Detects Alcohol in Steatotic Liver Disease Medscape A novel, accurate, easy-to-use biomarker test might help flag excessive alcohol use in steatotic liver disease (SLD), distinguishing metabolic and alcohol-associated liver disease (MetALD) and ALD from metabolic dysfunction-associated SLD (MASLD). The new …
- Study Identifies Novel Stress-Inflammation Pathway in AD Medscape Patients and physicians have long known that psychological stress can exacerbate symptoms of atopic dermatitis (AD), but the exact mechanism has been unclear. New research utilizing mouse models and patient data sheds light on specific neural pathways that …
- Mayo Clinic-Led Study Maps Mechanism for Vitamin D’s Effect on IBD Symptoms Natural News Introduction A new study led by Mayo Clinic researchers has mapped a precise biological mechanism explaining how vitamin D supplementation improves symptoms in patients with inflammatory bowel disease (IBD), according to a report published in the journal …
- Stock Market Today (LIVE): S&P 500 Wipes Out Iran War Losses; UPS Wants RFID on Every Package; Citi Puts Alphabet on 90-Day Watch The Motley Fool USA 📌 Top story -- scroll down for more updates Closing Bell 4:04 pm Stocks climbed Tuesday as traders looked past stalled U.S.-Iran talks, betting a deal is still within reach. The S&P 500 rose 1.2% to within 1% of its 52-week high, with the Nasdaq up 2% …
- Six expats who satisfy the appetites and help the poor of Cuenca; Illegal pill factory is busted; Gasoline prices rise again; Enjoy the natural beauty of El Pan Cuenca High Life Bored? – (De El Mercurio del sábado, 11/4) Naturaleza y vida rural (Nature and rural life) – The canton of El Pan, 63 km. northeast of Cuenca, offers visitors gastronomic routes, country estates, and hands-on experiences. Some of the attractions are …
- Taiho Ventures, LLC Celebrates 10th Anniversary The AI Journal TOKYO and MENLO PARK, Calif., April 15, 2026 /PRNewswire/ — Taiho Pharmaceutical Co., Ltd. (Taiho Pharmaceutical) and Taiho Ventures, LLC (TVL), a strategic corporate venture capital (CVC) arm of Taiho Pharmaceutical, announced on April 15 that TVL …
- Stock split and bonus issue both announced - Check record date, ratio and stock performance Business Today Pharma player Anlon Healthcare has approved corporate restructuring measures such as a stock split and bonus share issuance. For stock split, the stock will be divided in a ratio of 1:5 (Rs 10 to Rs 2 face value). In case of bonus shares, the company will …
- Insilico Medicine Enhances MMAI Gym with Benchmark Leaderboard Portals to Advance Scientific Research and Drug Discovery Bioengineer.org CAMBRIDGE, Mass., April 14, 2026 — Insilico Medicine, a pioneering clinical-stage biotechnology company leveraging generative artificial intelligence (AI) to revolutionize scientific research and drug discovery, has announced a significant expansion of its …
- 8 in 10 Georgians want health insurance subsidies kept The Georgia Sun Americans are very divided on major issues, as are Georgians. But there is one thing we agree on- our citizens need healthcare insurance, as will be discussed below, examining polling data. Unfortunately, it is very difficult to even understand our non- …
- <![CDATA[Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals ]]> Pharmaceutical Executive Regeneron Pharmaceuticals and Telix Pharmaceuticals agreed to a collaboration aiming to advance next-generation radiopharmaceutical therapies. Emerging Pharma Leaders nominations are now open! Do you know someone who can make tough decisions that continue …
- <![CDATA[FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment ]]> Pharmaceutical Executive Replimune Group received a complete response letter (CRL) from FDA for its biologics license application (BLA) seeking approval of RP1 in combination with nivolumab for advanced melanoma. Emerging Pharma Leaders nominations are now open! Do you know …
- <![CDATA[Travere Therapeutics’ Filspari Receives Full FDA Approval ]]> Pharmaceutical Executive FDA fully approved Filspari (sparsentan) for focal segmental glomerulosclerosis, (FSGS), making it the first and only approved treatment for the rare kidney disease. Emerging Pharma Leaders nominations are now open! Do you know someone who can make tough …
- <![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]> Pharmaceutical Executive AbbVie announced a global licensing agreement with China-based Haisco Pharmaceutical to manufacture, commercialize, and develop novel medicines for the treatment of pain. Emerging Pharma Leaders nominations are now open! Do you know someone who can make …
- Pharma 5.0, Sustainability & Security: PHARMAP 2026 brings pharma’s future into focus Pharmaceutical Technology As the pharmaceutical industry navigates a series of interconnected industry challenges, the pharma community’s attention turns to Amsterdam. Later this month, major sector players gather for PHARMAP Congress 2026, scheduled for 20–21 April in the …
- EU sees 2025 pharma export uptick amid competitiveness concerns Pharmaceutical Technology New figures debuted by the European Union (EU) have uncovered a significant rise in the year-on-year value of pharma trade seen across the region in 2025 – stats the EU says represent a record trade balance for its medicines sector. In 2025, the value of …
- Midterm Polling Gives Senate Republicans a Path to Victory Townhall With the midterms approaching, Republicans are zeroing in on a targeted strategy to win back swing voters and Trump voters who don’t typically turn out in off-year elections. Those voters will be critical to maintaining a Republican majority in the Senate …
- Novo teams with OpenAI; Ideaya gets muted response to eye drug data BioPharma Dive Today, a brief rundown of news from Novo Nordisk and Regeneron Pharmaceuticals, as well as updates from Ideaya Biosciences, Neomorph and GSK that you may have missed. Novo Nordisk is partnering with OpenAI in a deal meant to help speed its drug development …
- Savara To Present New Data at the American Thoracic Society (ATS) 2026 International Conference The Barre-Montpelier Times Argus - Vermont LANGHORNE, Pa.--(BUSINESS WIRE)--Apr 14, 2026-- Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the acceptance of one oral presentation and two poster presentations at the ATS …
- Beef vs. Chicken: Surprising Results From New Prediabetes Study SciTechDaily New research explores how specific dietary protein choices influence metabolic health in individuals at risk for type 2 diabetes. The findings challenge common assumptions and add nuance to how diet impacts key biological processes linked to disease …
- 16 kids dead, a Rs 574 cr ‘racket’: The pharma group the system refuses to stop The News Minute This is the first part of an investigative series examining pharmaceutical companies linked to the deaths of children from contaminated medicines, and the regulatory failures that allowed them to keep operating. This series is supported by the Thakur …
- Questex’s Fierce Biotech Announces 2026 Fierce Outsourcing Award Winners, Honoring Excellence Across the Drug Development Ecosystem EIN Presswire NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Questex’s Fierce Biotech today announces the winners of the 2026 Fierce Outsourcing Awards, recognizing the companies and teams driving innovation, performance, and partnership across the outsourced drug …
- Italy’s surprise rise in exports to US masks deep fragility to tariffs Times LIVE Share current article via EmailShare current article via FacebookShare current article via TwitterShare current article via LinkedIn Italy was the only major EU country whose exports to the US grew last year despite Donald Trump’s tariffs. The result was …
- Fierce Biotech Layoff Tracker 2026: Astellas shutters cell therapy site; Replimune reduces staff Fierce Biotech Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over year, prompting the need for another edition of this …
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions Fierce Biotech As artificial intelligence continues to rewrite the rules in countless industries, pharma companies are increasingly getting on board—with their AI tie-ups ranging from narrow projects to enterprise-wide initiatives. Count Novo Nordisk in the latter …
- Generic Sterile Injectable Market Size to Lead USD 124.44 Billion by 2035 Rising Demand for Affordable Injectables and Patent Expirations EIN Presswire Ottawa, April 14, 2026 (GLOBE NEWSWIRE) -- According to Precedence Research, the global generic sterile injectable market size will grow from USD 56.41 billion in 2026 to nearly USD 124.44 billion by 2035, accelerating with a solid CAGR of 9.29% from 2026 …
- Digestive Health Products Market Size Forecasted to Reach USD 290.31 Bn By 2035 Rising Health Awareness and Digestive Disorders EIN Presswire Ottawa, April 14, 2026 (GLOBE NEWSWIRE) -- Rising digestive disorders, growing gut health awareness, and increasing demand for preventive nutrition. What is the Digestive Health Products Market Size in 2026? The global digestive health products market size …
- EU Asked to Include Microbial Proteins & Fermentation in Upcoming Biotech Act Green Queen 5 Mins Read The EU should name fermentation-derived food ingredients as a covered technology category and boost investment for scale-up in its second Biotech Act, due later this year, according to a new policy brief. As the EU faces mounting criticism for …
- Joints, Weight, and Mental Health: Ixekizumab + Tirzepatide for PsA, With Joseph Merola, MD Consultant Live Combination treatment with ixekizumab (Taltz) and tirzepatide (Zepbound) produced superior joint outcomes compared with ixekizumab alone in a population of patients with difficult-to-treat psoriatic arthritis (PsA) and excess body weight. Joseph F. Merola …
- Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations EIN Presswire Press release – No. 7 / 2026 Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations Bringing significant experience from Vertex Pharmaceuticals and Shire Copenhagen, Denmark and Boston, Massachusetts, April 14, 2026 - …
- Nemolizumab Findings Positive for Younger Kids With AD Medscape DENVER — Clearance of lesions, lowered disease severity, and improved itch ratings were demonstrated with nemolizumab in children 2-11 years old with moderate-to-severe atopic dermatitis (AD) in a phase 2 open-label study. The FDA approved nemolizumab in …
- ‘Antichrist spirit’: Marjorie Taylor Greene slams Trump’s Jesus image as ‘more than blasphemy’ LifeSite News The former Georgia congresswoman and Trump supporter said on social media that 'I completely denounce' the president's now-deleted post. (LifeSiteNews) — Former Georgia Republican Congresswoman Marjorie Taylor Greene slammed President …
- Novo Nordisk and OpenAI forge alliance to drive speedy drug development Pharmaceutical Technology Novo Nordisk has partnered with tech giant OpenAI to expedite its drug development efforts, as the Danish pharma looks to fend off stiff competition from obesity market rival Eli Lilly. Through this collaboration, Novo will incorporate OpenAI’s artificial …
- FDA asks 2,200 drug developers to make trial results public, ramping up transparency push BioSpace The FDA has written to more than 2,200 study sponsors reminding them of their obligation to make their results publicly available on a federal clinical trials database—a move that falls in line with the agency’s aim of improving transparency across the …
- Brains Bioceutical Appoints Dr. Priyajit "Bobby" Prasad as Chairman of Medical Advisory Board Voice of Alexandria - Minnesota VANCOUVER, Canada, April 14, 2026 (EZ Newswire) -- Brains Bioceutical Corp. ("Brains Bio"), a global life sciences company advancing a clinically validated portfolio of therapeutic and pharmaceutical programs, today announced the appointment of …
- Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma EIN Presswire FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling access to accelerated and rolling review FDA clearance of IND application enables initiation of the SHINE …
- Analysis-Italy’s surprise rise in exports to US masks deep fragility to tariffs WHTC - Michigan By Antonella Cinelli and Valentina Consiglio ROME, April 14 (Reuters) – Italy was the only major EU country whose exports to the United States grew last year despite Donald Trump’s tariffs. The result was hailed by Rome’s government, but a closer look at …
- Business News | Pharma Sector Must 'leapfrog' into Innovation Phase to Meet 2047 Goals: Pharmexcil Chairman Latestly New Delhi [India], April 14 (ANI): The Indian pharmaceutical industry must enter a dedicated "innovation phase" over the next five years if it is to meet its long-term global ambitions, said Namit Joshi, Chairman of the Pharmaceuticals Export …
- Roflumilast safe nonsteroidal option for infants with eczema Healio News April 13, 2026 3 min watch Key takeaways: Roflumilast cream 0.05% was safe and well tolerated among infants with mild to moderate atopic dermatitis. Roflumilast also improved IGA and EASI scores, as well as itch responses, for participants. DENVER — …
- India News | Over 1.28 Lakh Raids Conducted and More Than 59,000 Cylinders Seized Across the Country Since March 2026 Latestly New Delhi [India], April 14 (ANI): The Government of India convened a briefing at the National Media Centre on Monday. Officials from the Ministries of Petroleum and Natural Gas, Ports, Shipping and Waterways, and External Affairs provided updates on fuel …
- Govt eyes shift to value-led innovation in pharma Awaz The Voice New Delhi The Indian pharmaceutical industry aims for a strategic transition from its traditional role as a volume-driven generics producer toward becoming a value-led innovation hub focused on biologics and biosimilars. This shift comes as the government …
- Neomorph raises $100M for molecular glues; Spyre's ulcerative colitis data Endpoints News Plus, news about AbbVie, SynOx, Eli Lilly’s Jaypirca, ImageneBio, Nxera Pharma, Neurocrine and Novartis: Neomorph raises $100M more for molecular glues: San Diego-based Neomorph has …
- Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech. Hindustan Times Big Pharma is on the prowl for biotech companies, but it’s acting stingy. Biotech stocks continue to outperform, even after a rally last year. Deal sizes are smaller, valuations are reasonable and buyers are walking away from megadeals when sellers push …
- NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference EIN Presswire VANCOUVER, British Columbia, April 13, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury …
- Business : KPJ , Novo Nordisk Launch Science-Based Obesity Care Programme Bernama KUALA LUMPUR, April 13 (Bernama) -- The KPJ Weight Management Programme, a collaboration between KPJ Healthcare and Novo Nordisk Pharma (Malaysia), a global healthcare company specialising in diabetes and obesity therapies, is set to improve obesity care …
- Top stocks in news: M&M, Adani Green, L&T, Swiggy, Lupin, Muthoot, ICICI Pru AMC, MGL Business Today Indian benchmark indices settled higher on Friday on the back of support from global and domestic cues and de-escalating tensions in West Asia. The BSE Sensex surged 918.60 points, or 1.20 per cent, to close at 77,550.25, while NSE's Nifty50 jumped 275 …
- Which Dividend Pharma Stock Should a Value Investor Choose Today? Nasdaq Key Points Values aren't always easy to find in the pharma sector. Bristol Myers Squibb has stable revenue, plus a strong dividend payout. Its pipeline of drugs needs to keep growing to offset concerns around its legacy portfolio. 10 stocks we like …
- Stocks in news: LIC, Maruti Suzuki, Sun Pharma, TCS, HUL The Economic Times Markets extended their upmove on Friday, supported by favourable cues, and gained over 1%. Analysts say the Nifty is witnessing a steady recovery and indications favor a gradual rise towards the 24,300-24,700 zone. A further cool-off in the volatility …
- Australia's Telix Pharma announces strategic radiopharma collaboration worth $535 M with Regeneron Biospectrum Asia Australia's Telix Pharma announces strategic radiopharma collaboration worth $535 M with Regeneron April 13, 2026 | Monday | News Telix and Regeneron to co-develop and co-commercialise next-generation radiopharmaceutical therapies in a 50/50 cost …
- Denk Pharma partners with FIP to advance global access to quality medicines Kenya Broadcasting Corporation Denk Pharma and the International Pharmaceutical Federation (FIP) have announced a strategic partnership to advance access to safe, high-quality medicines and strengthen pharmaceutical practice worldwide. As part of the partnership, Denk Pharma will …
- Business News | Pharma and Healthcare Companies to Face Continued Margin Pressure: HDFC Securities Latestly New Delhi [India], April 12 (ANI): The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC Securities. "We project …